title: Response of proinflammatory and anti-inflammatory cytokines in calves with subclinical bovine viral diarrhea challenged with bovine herpesvirus-1.
abstract: The aim of this work was to investigate the susceptibility of calves infected with bovine viral diarrhea virus (BVDV) against secondary infections. For this purpose, the profile of cytokines implicated in the immune response of calves experimentally infected with a non-cytopathic strain of BVDV type-1 and challenged with bovine herpesvirus 1.1 (BHV-1.1) was evaluated in comparison with healthy animals challenged only with BHV-1.1. The immune response was measured by serum concentrations of cytokines (IL-1β, TNFα, IFNγ, IL-12, IL-4 and IL-10), acute phase proteins (haptoglobin, serum amyloid A and fibrinogen) and BVDV and BHV-1.1 specific antibodies. BVDV-infected calves displayed a great secretion of TNFα and reduced production of IL-10 following BHV-1 infection, leading to an exacerbation of the inflammatory response and to the development of more intense clinical symptoms and lesions than those observed in healthy animals BHV-1-inoculated. A Th1 immune response, based on IFNγ production and on the absence of significant changes in IL-4 production, was observed in both groups of BHV-1-infected calves. However, whereas the animals inoculated only with BHV-1 presented an IFNγ response from the start of the study and high expression of IL-12, the BVDV-infected calves showed a delay in the IFNγ production and low levels of IL-12. This alteration in the kinetic and magnitude of these cytokines, involved in cytotoxic mechanisms responsible for limiting the spread of secondary pathogens, facilitated the dissemination of BHV-1.1 in BVDV-infected calves.
authors.affiliation: Department of Comparative Pathology, Veterinary Faculty, University of Córdoba-Agrifood Campus of International Excellence (ceiA3), Campus de Rabanales, 14014, Córdoba, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Risalde
authors.forename: V
authors.initials: V
authors.lastname: Molina
authors.forename: P J
authors.initials: PJ
authors.lastname: Sánchez-Cordón
authors.forename: M
authors.initials: M
authors.lastname: Pedrera
authors.forename: R
authors.initials: R
authors.lastname: Panadero
authors.forename: F
authors.initials: F
authors.lastname: Romero-Palomo
authors.forename: J C
authors.initials: JC
authors.lastname: Gómez-Villamandos
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis / Q000502:physiology; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D001912:Bovine Virus Diarrhea-Mucosal Disease / Q000276:immunology* / Q000821:virology; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology* / Q000382:microbiology / Q000821:virology; D016207:Cytokines / Q000097:blood / Q000502:physiology*; D030241:Diarrhea Virus 1, Bovine Viral / Q000276:immunology*; D004198:Disease Susceptibility / Q000276:immunology / Q000382:microbiology / Q000662:veterinary / Q000821:virology; D006566:Herpesviridae Infections / Q000276:immunology / Q000382:microbiology / Q000662:veterinary* / Q000821:virology; D007242:Herpesvirus 1, Bovine / Q000276:immunology*; D007371:Interferon-gamma / Q000097:blood / Q000502:physiology; D016753:Interleukin-10 / Q000097:blood / Q000502:physiology; D018664:Interleukin-12 / Q000097:blood / Q000502:physiology; D053583:Interleukin-1beta / Q000097:blood / Q000502:physiology; D015847:Interleukin-4 / Q000097:blood / Q000502:physiology; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000502:physiology
chemical_list: D000209:Acute-Phase Proteins; D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D016207:Cytokines; D053583:Interleukin-1beta; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D018664:Interleukin-12; D015847:Interleukin-4; D007371:Interferon-gamma